Raiffeisen Bank International AG purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) during the 4th quarter, Holdings Channel reports. The fund purchased 51,245 shares of the financial services provider’s stock, valued at approximately $2,505,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of TRUP. Jones Financial Companies Lllp increased its stake in Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 238 shares during the period. Coppell Advisory Solutions LLC increased its stake in Trupanion by 58.3% in the fourth quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider’s stock worth $61,000 after purchasing an additional 460 shares during the period. SBI Securities Co. Ltd. purchased a new stake in Trupanion in the fourth quarter worth $25,000. Swiss National Bank increased its stake in Trupanion by 1.1% in the fourth quarter. Swiss National Bank now owns 66,310 shares of the financial services provider’s stock worth $3,196,000 after purchasing an additional 700 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Trupanion by 4.0% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 18,745 shares of the financial services provider’s stock worth $904,000 after purchasing an additional 717 shares during the period.
Trupanion Stock Performance
Shares of Trupanion stock opened at $45.43 on Friday. The firm has a market cap of $1.94 billion, a P/E ratio of -197.52, a P/E/G ratio of 6.02 and a beta of 1.72. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a 12 month low of $25.90 and a 12 month high of $57.90. The stock’s fifty day moving average price is $37.69 and its 200-day moving average price is $44.39.
Analyst Ratings Changes
A number of analysts have weighed in on TRUP shares. Lake Street Capital reduced their target price on Trupanion from $65.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, May 2nd. Stifel Nicolaus reduced their target price on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Finally, Piper Sandler reduced their target price on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $51.80.
Check Out Our Latest Stock Report on TRUP
Insider Activity
In related news, CEO Margaret Tooth sold 2,294 shares of the firm’s stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the sale, the chief executive officer now owns 118,784 shares of the company’s stock, valued at $3,728,629.76. This trade represents a 1.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Fawwad Qureshi sold 1,373 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the sale, the chief financial officer now directly owns 2,416 shares in the company, valued at approximately $82,675.52. The trade was a 36.24% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,792 shares of company stock worth $1,122,802. Company insiders own 5.50% of the company’s stock.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- Business Services Stocks Investing
- Walmart Stock Alert: Big Price Move Expected Soon
- What is a Microcap Stock? Everything You Need to Know
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Are Penny Stocks a Good Fit for Your Portfolio?
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.